Boston Scientific Corp (BSX)
67.24
+1.01
(+1.52%)
USD |
NYSE |
Mar 18, 16:00
67.24
0.00 (0.00%)
After-Hours: 20:00
Boston Scientific SG&A Expense (Quarterly): 1.379B for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.379B |
September 30, 2023 | 1.242B |
June 30, 2023 | 1.354B |
March 31, 2023 | 1.215B |
December 31, 2022 | 1.163B |
September 30, 2022 | 1.132B |
June 30, 2022 | 1.165B |
March 31, 2022 | 1.06B |
December 31, 2021 | 1.153B |
September 30, 2021 | 1.066B |
June 30, 2021 | 1.121B |
March 31, 2021 | 1.019B |
December 31, 2020 | 1.027B |
September 30, 2020 | 984.00M |
June 30, 2020 | 798.00M |
March 31, 2020 | 978.00M |
December 31, 2019 | 1.092B |
September 30, 2019 | 1.012B |
June 30, 2019 | 968.00M |
March 31, 2019 | 869.00M |
December 31, 2018 | 953.00M |
September 30, 2018 | 870.00M |
June 30, 2018 | 886.00M |
March 31, 2018 | 860.00M |
December 31, 2017 | 886.00M |
Date | Value |
---|---|
September 30, 2017 | 800.00M |
June 30, 2017 | 815.00M |
March 31, 2017 | 794.00M |
December 31, 2016 | 831.00M |
September 30, 2016 | 772.00M |
June 30, 2016 | 779.00M |
March 31, 2016 | 716.00M |
December 31, 2015 | 778.00M |
September 30, 2015 | 729.00M |
June 30, 2015 | 700.00M |
March 31, 2015 | 668.00M |
December 31, 2014 | 752.00M |
September 30, 2014 | 741.00M |
June 30, 2014 | 743.00M |
March 31, 2014 | 666.00M |
December 31, 2013 | 724.00M |
September 30, 2013 | 658.00M |
June 30, 2013 | 661.00M |
March 31, 2013 | 631.00M |
December 31, 2012 | 640.00M |
September 30, 2012 | 589.00M |
June 30, 2012 | 648.00M |
March 31, 2012 | 659.00M |
December 31, 2011 | 481.00M |
September 30, 2011 | 665.00M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
798.00M
Minimum
Jun 2020
1.379B
Maximum
Dec 2023
1.090B
Average
1.079B
Median
SG&A Expense (Quarterly) Benchmarks
Stryker Corp | 1.941B |
Abbott Laboratories | 2.724B |
Haemonetics Corp | 111.71M |
Intuitive Surgical Inc | 567.10M |
Axonics Inc | 66.19M |